FinEdge Labs
A

ATR

ATRUnverified
6 segments tracked|7 years of data|Annual (10-K)
Total Revenue
$3.8B5.4%
FY2025
Operating Segments
6
Active segments
Blended Margin
0.0%
Operating margin
Highest Margin
0.0%
Pharma
Segment Shift

Pharma has grown from 100.0% to 45.6% of total revenue since FY2019, with 0.0% operating margins.

Segment Revenue Over Time

Revenue Mix

Segment Breakdown — FY2025

SegmentRevenueOp. IncomeMargin% of TotalYoY
Pharma$1.7B$00.0%45.6%+0.0%
Beauty$1.3B$00.0%35.1%+0.0%
Closures$737M$00.0%19.3%+0.0%

Want more? Unlock the full analysis.

Sign up free to access quarterly data, financial statements, trend analysis, geographic segments, Excel exports, and cross-company comparisons.

Get Started Free